Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

deborah

XTuit Pharmaceuticals move to appoint biotech veteran as CEO

March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing XTuit Pharmaceuticals

XTuit Pharmaceuticals has revealed the appointment of Deborah Dunshire as its new President and CEO. XTuit Pharmaceuticals is a biotech …
Appointment
shutterstock_141299494

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …
Feature
shutterstock_212432119

Combination immunotherapy shows promise in castration-resistant prostate cancer

March 13, 2017 Research and Development, Sales and Marketing prostate cancer

Researchers at the University of Texas MD Anderson Cancer Center have found that castration-resistant prostate cancer responds well to a …
News
320px-human_embryonic_stem_cells_only_a

TiGenix announces success of novel heart attack stem cell trial

March 13, 2017 Research and Development, Sales and Marketing Stem cells, TiGenix, heart attack

Belgium’s TiGenix has announced the success of its top-line Phase 2/3 study investigating the effects of donor-derived expanded cardiac stem …
News
oxford-biodynamics-logo

Oxford BioDynamics installs new SVP of Commercial Development

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioDynamics

Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The past week in the industry has brought much hope for patients with the news of significant research data developments …
News
thomas_headshot

BMS finds replacement for retiring CSO

March 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …
Appointment
kingscollegechapelwest

Cambridge University announces ‘world-leading’ industry-academia collaboration initiative

March 9, 2017 Medical Communications, Research and Development University of Cambridge

The University of Cambridge has announced a new initiative that seeks to build a bridge between industry and academia in …
News
charity_gifts_for_children_with_cancer_foundation_vanessa_isabel

Looming Brexit sparks fears for child cancer trials, experts warn

March 9, 2017 Medical Communications, Research and Development EU, ICR, brexit

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …
News
park-profile-trans

Keapstone Therapeutics created out of Sheffield Uni and Parkinson’s UK link

March 8, 2017 Research and Development Keapstone therapeutics, Parkinson's UK, University of Sheffield

The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual biotech company for developing therapies against …
News
acute_leukemia-all

New drug combination gives hope for acute myeloid leukaemia treatment

March 8, 2017 Research and Development acute myeloid leukaemia

A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute …
News
trevor-philips

Vectura’s COO set to step down

March 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
Appointment
amgen_hq

FDA and NICE approve of first new hyperparathyroidism drug in 12 years

March 8, 2017 Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism

The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …
News
web_scientist-filling-out-form---credit-national-institutes-of-health

Diabetes drug could be key to treating aggressive breast cancer, research suggests

March 8, 2017 Research and Development Cancer, diabetes

Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …
News
child

Research gives hope of potential treatment for most deadly paediatric brain tumour

March 8, 2017 Research and Development

A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025